0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Coronary Artery Bypass Grafts (CABG) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: July 2025
|
Report Code: QYRE-Auto-25X2252
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Coronary Artery Bypass Grafts CABG Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Coronary Artery Bypass Grafts (CABG) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-25X2252
Report
July 2025
Pages:122
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Coronary Artery Bypass Grafts (CABG) Market Size

In 2024, the global market size of Coronary Artery Bypass Grafts (CABG) was estimated to be worth US$ 142 million and is forecast to reach approximately US$ 202 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.

Coronary Artery Bypass Grafts (CABG) Market

Coronary Artery Bypass Grafts (CABG) Market

Coronary artery bypass surgery, also known as coronary artery bypass graft (CABG) surgery, and colloquially heart bypass or bypass surgery, is a surgical procedure to restore normal blood flow to an obstructed coronary artery.
Global Coronary Artery Bypass Grafts (CABG) key players include Medtronic, Getinge Group, LivaNova, Terumo, Boston Scientific, etc. Global top five manufacturers hold a share about 65%.
North America is the largest market, with a share over 35%, followed by Europe and Asia-Pacific, both have a share about 55 percent.
In terms of product, Saphenous Vein Grafts is the largest segment, with a share about 70%. And in terms of application, the largest application is Traditional CABG, followed by Nontraditional CABG.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Coronary Artery Bypass Grafts (CABG), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coronary Artery Bypass Grafts (CABG).
The Coronary Artery Bypass Grafts (CABG) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Coronary Artery Bypass Grafts (CABG) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Coronary Artery Bypass Grafts (CABG) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation

Scope of Coronary Artery Bypass Grafts (CABG) Market Report

Report Metric Details
Report Name Coronary Artery Bypass Grafts (CABG) Market
Forecasted market size in 2031 approximately US$ 202 million
CAGR 5.2%
Forecasted years 2025 - 2031
Segment by Type
  • Saphenous Vein Grafts
  • Internal Thoracic Artery Grafts
  • Other
Segment by Application
  • Traditional CABG
  • Nontraditional CABG
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Medtronic, Getinge Group, LivaNova, Terumo, Boston Scientific, Stryker, Edwards Lifesciences, Genesee Biomedical, Karl Storz GmbH
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
  • Chapter 2: Revenue of Coronary Artery Bypass Grafts (CABG) in global and regional level.
  • Chapter 3: Detailed analysis of Coronary Artery Bypass Grafts (CABG) company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Coronary Artery Bypass Grafts (CABG) revenue, gross margin, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the Coronary Artery Bypass Grafts (CABG) Market size in 2031?

Ans: The Coronary Artery Bypass Grafts (CABG) Market size in 2031 will be approximately US$ 202 million.

What is the market share of major companies in Coronary Artery Bypass Grafts (CABG) Market?

Ans: Global top five manufacturers hold a share about 65%.

What is the Coronary Artery Bypass Grafts (CABG) Market share by type?

Ans: In terms of product, Saphenous Vein Grafts is the largest segment, with a share about 70%.

Who are the main players in the Coronary Artery Bypass Grafts (CABG) Market report?

Ans: The main players in the Coronary Artery Bypass Grafts (CABG) Market are Medtronic, Getinge Group, LivaNova, Terumo, Boston Scientific, Stryker, Edwards Lifesciences, Genesee Biomedical, Karl Storz GmbH

What are the Application segmentation covered in the Coronary Artery Bypass Grafts (CABG) Market report?

Ans: The Applications covered in the Coronary Artery Bypass Grafts (CABG) Market report are Traditional CABG, Nontraditional CABG

What are the Type segmentation covered in the Coronary Artery Bypass Grafts (CABG) Market report?

Ans: The Types covered in the Coronary Artery Bypass Grafts (CABG) Market report are Saphenous Vein Grafts, Internal Thoracic Artery Grafts, Other

1 Study Coverage
1.1 Coronary Artery Bypass Grafts (CABG) Product Introduction
1.2 Market by Type
1.2.1 Global Coronary Artery Bypass Grafts (CABG) Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Saphenous Vein Grafts
1.2.3 Internal Thoracic Artery Grafts
1.2.4 Other
1.3 Market by Application
1.3.1 Global Coronary Artery Bypass Grafts (CABG) Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Traditional CABG
1.3.3 Nontraditional CABG
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Coronary Artery Bypass Grafts (CABG) Market Size Estimates and Forecasts
2.2 Coronary Artery Bypass Grafts (CABG) Market Size by Region: 2024 Versus 2031
2.2.1 Global Coronary Artery Bypass Grafts (CABG) Revenue by Region: 2020-2025
2.2.2 Global Coronary Artery Bypass Grafts (CABG) Revenue Forecast by Region (2026-2031)
2.2.3 Global Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Coronary Artery Bypass Grafts (CABG) Revenue by Type (2020-2031)
3.1.2 Global Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Coronary Artery Bypass Grafts (CABG) Revenue by Application (2020-2031)
3.2.2 Global Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Saphenous Vein Grafts of Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Application
3.3.2 Internal Thoracic Artery Grafts of Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Application
3.3.3 Other of Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Application
4 Global Coronary Artery Bypass Grafts (CABG) by Company
4.1 Global Coronary Artery Bypass Grafts (CABG) Revenue by Company (2020-2025)
4.2 Global Coronary Artery Bypass Grafts (CABG) Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Coronary Artery Bypass Grafts (CABG) Companies around the World: Ranking by Revenue
4.3.2 Global Coronary Artery Bypass Grafts (CABG) Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Coronary Artery Bypass Grafts (CABG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Coronary Artery Bypass Grafts (CABG) Companies Headquarters & Product Type
4.4.1 Global Coronary Artery Bypass Grafts (CABG) Companies Headquarters
4.4.2 Date of International Companies Enter into Coronary Artery Bypass Grafts (CABG) Market
4.4.3 Global Coronary Artery Bypass Grafts (CABG) Companies Product & Service
4.4.4 Saphenous Vein Grafts Revenue Market Share of Coronary Artery Bypass Grafts (CABG) by Company
4.4.5 Internal Thoracic Artery Grafts Revenue Market Share of Coronary Artery Bypass Grafts (CABG) by Company
4.4.6 Other Revenue Market Share of Coronary Artery Bypass Grafts (CABG) by Company
4.5 Global Coronary Artery Bypass Grafts (CABG) Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Medtronic
5.1.1 Medtronic Corporation Information
5.1.2 Medtronic Description, Business Overview
5.1.3 Medtronic Coronary Artery Bypass Grafts (CABG) Products Offered
5.1.4 Medtronic Coronary Artery Bypass Grafts (CABG) Revenue and Gross Margin (2020-2025)
5.1.5 Medtronic Coronary Artery Bypass Grafts (CABG) Revenue by Product in 2024
5.1.6 Medtronic Coronary Artery Bypass Grafts (CABG) Revenue by Application in 2024
5.1.7 Medtronic Coronary Artery Bypass Grafts (CABG) Revenue by Geographic Area in 2024
5.1.8 Medtronic Recent Developments
5.2 Getinge Group
5.2.1 Getinge Group Corporation Information
5.2.2 Getinge Group Description, Business Overview
5.2.3 Getinge Group Coronary Artery Bypass Grafts (CABG) Products Offered
5.2.4 Getinge Group Coronary Artery Bypass Grafts (CABG) Revenue and Gross Margin (2020-2025)
5.2.5 Getinge Group Coronary Artery Bypass Grafts (CABG) Revenue by Product in 2024
5.2.6 Getinge Group Coronary Artery Bypass Grafts (CABG) Revenue by Application in 2024
5.2.7 Getinge Group Coronary Artery Bypass Grafts (CABG) Revenue by Geographic Area in 2024
5.2.8 Getinge Group Recent Developments
5.3 LivaNova
5.3.1 LivaNova Corporation Information
5.3.2 LivaNova Description, Business Overview
5.3.3 LivaNova Coronary Artery Bypass Grafts (CABG) Products Offered
5.3.4 LivaNova Coronary Artery Bypass Grafts (CABG) Revenue and Gross Margin (2020-2025)
5.3.5 LivaNova Coronary Artery Bypass Grafts (CABG) Revenue by Product in 2024
5.3.6 LivaNova Coronary Artery Bypass Grafts (CABG) Revenue by Application in 2024
5.3.7 LivaNova Coronary Artery Bypass Grafts (CABG) Revenue by Geographic Area in 2024
5.3.8 LivaNova Recent Developments
5.4 Terumo
5.4.1 Terumo Corporation Information
5.4.2 Terumo Description, Business Overview
5.4.3 Terumo Coronary Artery Bypass Grafts (CABG) Products Offered
5.4.4 Terumo Coronary Artery Bypass Grafts (CABG) Revenue and Gross Margin (2020-2025)
5.4.5 Terumo Coronary Artery Bypass Grafts (CABG) Revenue by Product in 2024
5.4.6 Terumo Coronary Artery Bypass Grafts (CABG) Revenue by Application in 2024
5.4.7 Terumo Coronary Artery Bypass Grafts (CABG) Revenue by Geographic Area in 2024
5.4.8 Terumo Recent Developments
5.5 Boston Scientific
5.5.1 Boston Scientific Corporation Information
5.5.2 Boston Scientific Description, Business Overview
5.5.3 Boston Scientific Coronary Artery Bypass Grafts (CABG) Products Offered
5.5.4 Boston Scientific Coronary Artery Bypass Grafts (CABG) Revenue and Gross Margin (2020-2025)
5.5.5 Boston Scientific Coronary Artery Bypass Grafts (CABG) Revenue by Product in 2024
5.5.6 Boston Scientific Coronary Artery Bypass Grafts (CABG) Revenue by Application in 2024
5.5.7 Boston Scientific Coronary Artery Bypass Grafts (CABG) Revenue by Geographic Area in 2024
5.5.8 Boston Scientific Recent Developments
5.6 Stryker
5.6.1 Stryker Corporation Information
5.6.2 Stryker Description, Business Overview
5.6.3 Stryker Coronary Artery Bypass Grafts (CABG) Products Offered
5.6.4 Stryker Coronary Artery Bypass Grafts (CABG) Revenue and Gross Margin (2020-2025)
5.6.5 Stryker Coronary Artery Bypass Grafts (CABG) Revenue by Product in 2024
5.6.6 Stryker Coronary Artery Bypass Grafts (CABG) Revenue by Application in 2024
5.6.7 Stryker Coronary Artery Bypass Grafts (CABG) Revenue by Geographic Area in 2024
5.6.8 Stryker Recent Developments
5.7 Edwards Lifesciences
5.7.1 Edwards Lifesciences Corporation Information
5.7.2 Edwards Lifesciences Description, Business Overview
5.7.3 Edwards Lifesciences Coronary Artery Bypass Grafts (CABG) Products Offered
5.7.4 Edwards Lifesciences Coronary Artery Bypass Grafts (CABG) Revenue and Gross Margin (2020-2025)
5.7.5 Edwards Lifesciences Coronary Artery Bypass Grafts (CABG) Revenue by Product in 2024
5.7.6 Edwards Lifesciences Coronary Artery Bypass Grafts (CABG) Revenue by Application in 2024
5.7.7 Edwards Lifesciences Coronary Artery Bypass Grafts (CABG) Revenue by Geographic Area in 2024
5.7.8 Edwards Lifesciences Recent Developments
5.8 Genesee Biomedical
5.8.1 Genesee Biomedical Corporation Information
5.8.2 Genesee Biomedical Description, Business Overview
5.8.3 Genesee Biomedical Coronary Artery Bypass Grafts (CABG) Products Offered
5.8.4 Genesee Biomedical Coronary Artery Bypass Grafts (CABG) Revenue and Gross Margin (2020-2025)
5.8.5 Genesee Biomedical Coronary Artery Bypass Grafts (CABG) Revenue by Product in 2024
5.8.6 Genesee Biomedical Coronary Artery Bypass Grafts (CABG) Revenue by Application in 2024
5.8.7 Genesee Biomedical Coronary Artery Bypass Grafts (CABG) Revenue by Geographic Area in 2024
5.8.8 Genesee Biomedical Recent Developments
5.9 Karl Storz GmbH
5.9.1 Karl Storz GmbH Corporation Information
5.9.2 Karl Storz GmbH Description, Business Overview
5.9.3 Karl Storz GmbH Coronary Artery Bypass Grafts (CABG) Products Offered
5.9.4 Karl Storz GmbH Coronary Artery Bypass Grafts (CABG) Revenue and Gross Margin (2020-2025)
5.9.5 Karl Storz GmbH Coronary Artery Bypass Grafts (CABG) Revenue by Product in 2024
5.9.6 Karl Storz GmbH Coronary Artery Bypass Grafts (CABG) Revenue by Application in 2024
5.9.7 Karl Storz GmbH Coronary Artery Bypass Grafts (CABG) Revenue by Geographic Area in 2024
5.9.8 Karl Storz GmbH Recent Developments
6 North America
6.1 North America Coronary Artery Bypass Grafts (CABG) Market Size YoY Growth 2020-2031
6.2 North America Coronary Artery Bypass Grafts (CABG) Market Facts & Figures by Country (2020-2031)
6.3 North America Coronary Artery Bypass Grafts (CABG) Revenue by Type (2020-2025)
6.4 North America Coronary Artery Bypass Grafts (CABG) Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Coronary Artery Bypass Grafts (CABG) Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Coronary Artery Bypass Grafts (CABG) Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Coronary Artery Bypass Grafts (CABG) Revenue by Type (2020-2025)
7.4 Asia-Pacific Coronary Artery Bypass Grafts (CABG) Revenue by Application (2020-2025)
8 Europe
8.1 Europe Coronary Artery Bypass Grafts (CABG) Market Size YoY Growth 2020-2031
8.2 Europe Coronary Artery Bypass Grafts (CABG) Market Facts & Figures by Country (2020-2031)
8.3 Europe Coronary Artery Bypass Grafts (CABG) Revenue by Type (2020-2025)
8.4 Europe Coronary Artery Bypass Grafts (CABG) Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Coronary Artery Bypass Grafts (CABG) Market Size YoY Growth 2020-2031
9.2 Latin America Coronary Artery Bypass Grafts (CABG) Market Facts & Figures by Country (2020-2031)
9.3 Latin America Coronary Artery Bypass Grafts (CABG) Revenue by Type (2020-2025)
9.4 Latin America Coronary Artery Bypass Grafts (CABG) Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Coronary Artery Bypass Grafts (CABG) Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Coronary Artery Bypass Grafts (CABG) Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Coronary Artery Bypass Grafts (CABG) Revenue by Type (2020-2025)
10.4 Middle East and Africa Coronary Artery Bypass Grafts (CABG) Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Coronary Artery Bypass Grafts (CABG) Supply Chain Analysis
11.2 Coronary Artery Bypass Grafts (CABG) Key Raw Materials and Upstream Suppliers
11.3 Coronary Artery Bypass Grafts (CABG) Clients Analysis
11.4 Coronary Artery Bypass Grafts (CABG) Sales Channel and Sales Model Analysis
11.4.1 Coronary Artery Bypass Grafts (CABG) Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Coronary Artery Bypass Grafts (CABG) Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Coronary Artery Bypass Grafts (CABG) Distributors
12 Coronary Artery Bypass Grafts (CABG) Market Dynamics
12.1 Coronary Artery Bypass Grafts (CABG) Industry Trends
12.2 Coronary Artery Bypass Grafts (CABG) Market Drivers
12.3 Coronary Artery Bypass Grafts (CABG) Market Challenges
12.4 Coronary Artery Bypass Grafts (CABG) Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
 Table 1. Global Coronary Artery Bypass Grafts (CABG) Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Coronary Artery Bypass Grafts (CABG) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Coronary Artery Bypass Grafts (CABG) Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Coronary Artery Bypass Grafts (CABG) Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Coronary Artery Bypass Grafts (CABG) Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 6. Global Coronary Artery Bypass Grafts (CABG) Revenue by Type (2020-2025) & (US$ Million)
 Table 7. Global Coronary Artery Bypass Grafts (CABG) Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 8. Global Coronary Artery Bypass Grafts (CABG) Revenue by Application (2020-2025) & (US$ Million)
 Table 9. Global Coronary Artery Bypass Grafts (CABG) Revenue Forecast by Application (2026-2031) & (US$ Million)
 Table 10. Coronary Artery Bypass Grafts (CABG) Revenue by Company (2020-2025) & (US$ Million)
 Table 11. Coronary Artery Bypass Grafts (CABG) Revenue Share by Company (2020-2025)
 Table 12. Ranking of Global Top Coronary Artery Bypass Grafts (CABG) Players by Revenue (US$ Million) in 2024
 Table 13. Global Coronary Artery Bypass Grafts (CABG) Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 14. Global Coronary Artery Bypass Grafts (CABG) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coronary Artery Bypass Grafts (CABG) as of 2024)
 Table 15. Global Coronary Artery Bypass Grafts (CABG) Companies Headquarters
 Table 16. Date of International Companies Enter into Coronary Artery Bypass Grafts (CABG) Market
 Table 17. Global Coronary Artery Bypass Grafts (CABG) Companies Product & Service
 Table 18. Global Coronary Artery Bypass Grafts (CABG) Mergers & Acquisitions, Expansion Plans
 Table 19. Medtronic Corporation Information
 Table 20. Medtronic Description and Business Overview
 Table 21. Medtronic Coronary Artery Bypass Grafts (CABG) Product
 Table 22. Medtronic Coronary Artery Bypass Grafts (CABG) Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 23. Medtronic Revenue Proportion of Coronary Artery Bypass Grafts (CABG) by Product in 2024
 Table 24. Medtronic Revenue Proportion of Coronary Artery Bypass Grafts (CABG) by Application in 2024
 Table 25. Medtronic Revenue Proportion of Coronary Artery Bypass Grafts (CABG) by Geographic Area in 2024
 Table 26. Medtronic Recent Developments
 Table 27. Getinge Group Corporation Information
 Table 28. Getinge Group Description and Business Overview
 Table 29. Getinge Group Coronary Artery Bypass Grafts (CABG) Product
 Table 30. Getinge Group Coronary Artery Bypass Grafts (CABG) Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 31. Getinge Group Revenue Proportion of Coronary Artery Bypass Grafts (CABG) by Product in 2024
 Table 32. Getinge Group Revenue Proportion of Coronary Artery Bypass Grafts (CABG) by Application in 2024
 Table 33. Getinge Group Revenue Proportion of Coronary Artery Bypass Grafts (CABG) by Geographic Area in 2024
 Table 34. Getinge Group Recent Developments
 Table 35. LivaNova Corporation Information
 Table 36. LivaNova Description and Business Overview
 Table 37. LivaNova Coronary Artery Bypass Grafts (CABG) Product
 Table 38. LivaNova Coronary Artery Bypass Grafts (CABG) Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 39. LivaNova Revenue Proportion of Coronary Artery Bypass Grafts (CABG) by Product in 2024
 Table 40. LivaNova Revenue Proportion of Coronary Artery Bypass Grafts (CABG) by Application in 2024
 Table 41. LivaNova Revenue Proportion of Coronary Artery Bypass Grafts (CABG) by Geographic Area in 2024
 Table 42. LivaNova Recent Developments
 Table 43. Terumo Corporation Information
 Table 44. Terumo Description and Business Overview
 Table 45. Terumo Coronary Artery Bypass Grafts (CABG) Product
 Table 46. Terumo Coronary Artery Bypass Grafts (CABG) Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Terumo Revenue Proportion of Coronary Artery Bypass Grafts (CABG) by Product in 2024
 Table 48. Terumo Revenue Proportion of Coronary Artery Bypass Grafts (CABG) by Application in 2024
 Table 49. Terumo Revenue Proportion of Coronary Artery Bypass Grafts (CABG) by Geographic Area in 2024
 Table 50. Terumo Recent Developments
 Table 51. Boston Scientific Corporation Information
 Table 52. Boston Scientific Description and Business Overview
 Table 53. Boston Scientific Coronary Artery Bypass Grafts (CABG) Product
 Table 54. Boston Scientific Coronary Artery Bypass Grafts (CABG) Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 55. Boston Scientific Revenue Proportion of Coronary Artery Bypass Grafts (CABG) by Product in 2024
 Table 56. Boston Scientific Revenue Proportion of Coronary Artery Bypass Grafts (CABG) by Application in 2024
 Table 57. Boston Scientific Revenue Proportion of Coronary Artery Bypass Grafts (CABG) by Geographic Area in 2024
 Table 58. Boston Scientific Recent Developments
 Table 59. Stryker Corporation Information
 Table 60. Stryker Description and Business Overview
 Table 61. Stryker Coronary Artery Bypass Grafts (CABG) Product
 Table 62. Stryker Coronary Artery Bypass Grafts (CABG) Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 63. Stryker Revenue Proportion of Coronary Artery Bypass Grafts (CABG) by Product in 2024
 Table 64. Stryker Revenue Proportion of Coronary Artery Bypass Grafts (CABG) by Application in 2024
 Table 65. Stryker Revenue Proportion of Coronary Artery Bypass Grafts (CABG) by Geographic Area in 2024
 Table 66. Stryker Recent Developments
 Table 67. Edwards Lifesciences Corporation Information
 Table 68. Edwards Lifesciences Description and Business Overview
 Table 69. Edwards Lifesciences Coronary Artery Bypass Grafts (CABG) Product
 Table 70. Edwards Lifesciences Coronary Artery Bypass Grafts (CABG) Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 71. Edwards Lifesciences Revenue Proportion of Coronary Artery Bypass Grafts (CABG) by Product in 2024
 Table 72. Edwards Lifesciences Revenue Proportion of Coronary Artery Bypass Grafts (CABG) by Application in 2024
 Table 73. Edwards Lifesciences Revenue Proportion of Coronary Artery Bypass Grafts (CABG) by Geographic Area in 2024
 Table 74. Edwards Lifesciences Recent Developments
 Table 75. Genesee Biomedical Corporation Information
 Table 76. Genesee Biomedical Description and Business Overview
 Table 77. Genesee Biomedical Coronary Artery Bypass Grafts (CABG) Product
 Table 78. Genesee Biomedical Coronary Artery Bypass Grafts (CABG) Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 79. Genesee Biomedical Revenue Proportion of Coronary Artery Bypass Grafts (CABG) by Product in 2024
 Table 80. Genesee Biomedical Revenue Proportion of Coronary Artery Bypass Grafts (CABG) by Application in 2024
 Table 81. Genesee Biomedical Revenue Proportion of Coronary Artery Bypass Grafts (CABG) by Geographic Area in 2024
 Table 82. Genesee Biomedical Recent Developments
 Table 83. Karl Storz GmbH Corporation Information
 Table 84. Karl Storz GmbH Description and Business Overview
 Table 85. Karl Storz GmbH Coronary Artery Bypass Grafts (CABG) Product
 Table 86. Karl Storz GmbH Coronary Artery Bypass Grafts (CABG) Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 87. Karl Storz GmbH Revenue Proportion of Coronary Artery Bypass Grafts (CABG) by Product in 2024
 Table 88. Karl Storz GmbH Revenue Proportion of Coronary Artery Bypass Grafts (CABG) by Application in 2024
 Table 89. Karl Storz GmbH Revenue Proportion of Coronary Artery Bypass Grafts (CABG) by Geographic Area in 2024
 Table 90. Karl Storz GmbH Recent Developments
 Table 91. North America Coronary Artery Bypass Grafts (CABG) Revenue by Country (2020-2025) & (US$ Million)
 Table 92. North America Coronary Artery Bypass Grafts (CABG) Revenue by Country (2026-2031) & (US$ Million)
 Table 93. North America Coronary Artery Bypass Grafts (CABG) Revenue by Type (2020-2025) & (US$ Million)
 Table 94. North America Coronary Artery Bypass Grafts (CABG) Revenue by Application (2020-2025) & (US$ Million)
 Table 95. Asia-Pacific Coronary Artery Bypass Grafts (CABG) Revenue by Region (2020-2025) & (US$ Million)
 Table 96. Asia-Pacific Coronary Artery Bypass Grafts (CABG) Revenue by Region (2026-2031) & (US$ Million)
 Table 97. Asia-Pacific Coronary Artery Bypass Grafts (CABG) Revenue by Type (2020-2025) & (US$ Million)
 Table 98. Asia-Pacific Coronary Artery Bypass Grafts (CABG) Revenue by Application (2020-2025) & (US$ Million)
 Table 99. Europe Coronary Artery Bypass Grafts (CABG) Revenue by Country (2020-2025) & (US$ Million)
 Table 100. Europe Coronary Artery Bypass Grafts (CABG) Revenue by Country (2026-2031) & (US$ Million)
 Table 101. Europe Coronary Artery Bypass Grafts (CABG) Revenue by Type (2020-2025) & (US$ Million)
 Table 102. Europe Coronary Artery Bypass Grafts (CABG) Revenue by Application (2020-2025) & (US$ Million)
 Table 103. Latin America Coronary Artery Bypass Grafts (CABG) Revenue by Country (2020-2025) & (US$ Million)
 Table 104. Latin America Coronary Artery Bypass Grafts (CABG) Revenue by Country (2026-2031) & (US$ Million)
 Table 105. Latin America Coronary Artery Bypass Grafts (CABG) Revenue by Type (2020-2025) & (US$ Million)
 Table 106. Latin America Coronary Artery Bypass Grafts (CABG) Revenue by Application (2020-2025) & (US$ Million)
 Table 107. Middle East and Africa Coronary Artery Bypass Grafts (CABG) Revenue by Country (2020-2025) & (US$ Million)
 Table 108. Middle East and Africa Coronary Artery Bypass Grafts (CABG) Revenue by Country (2026-2031) & (US$ Million)
 Table 109. Middle East and Africa Coronary Artery Bypass Grafts (CABG) Revenue by Type (2020-2025) & (US$ Million)
 Table 110. Middle East and Africa Coronary Artery Bypass Grafts (CABG) Revenue by Application (2020-2025) & (US$ Million)
 Table 111. Coronary Artery Bypass Grafts (CABG) Key Raw Materials, Industry Status and Trend
 Table 112. Coronary Artery Bypass Grafts (CABG) Key Raw Materials and Upstream Suppliers
 Table 113. Coronary Artery Bypass Grafts (CABG) Clients Status and Trend
 Table 114. Coronary Artery Bypass Grafts (CABG) Typical Clients
 Table 115. Coronary Artery Bypass Grafts (CABG) Distributors
 Table 116. Coronary Artery Bypass Grafts (CABG) Market Trends
 Table 117. Coronary Artery Bypass Grafts (CABG) Market Drivers
 Table 118. Coronary Artery Bypass Grafts (CABG) Market Challenges
 Table 119. Coronary Artery Bypass Grafts (CABG) Market Restraints
 Table 120. Research Programs/Design for This Report
 Table 121. Key Data Information from Secondary Sources
 Table 122. Key Data Information from Primary Sources


List of Figures
 Figure 1. Coronary Artery Bypass Grafts (CABG) Product Picture
 Figure 2. Global Coronary Artery Bypass Grafts (CABG) Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Type in 2024 & 2031
 Figure 4. Saphenous Vein Grafts Product Picture
 Figure 5. Internal Thoracic Artery Grafts Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Coronary Artery Bypass Grafts (CABG) Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 8. Global Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Application in 2024 & 2031
 Figure 9. Traditional CABG
 Figure 10. Nontraditional CABG
 Figure 11. Coronary Artery Bypass Grafts (CABG) Report Years Considered
 Figure 12. Global Coronary Artery Bypass Grafts (CABG) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Coronary Artery Bypass Grafts (CABG) Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Coronary Artery Bypass Grafts (CABG) Market Size Market Share by Region: 2024 Versus 2031
 Figure 15. Global Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Region (2020-2031)
 Figure 16. Global Coronary Artery Bypass Grafts (CABG) Revenue Market Share Forecast by Type (2020-2031)
 Figure 17. Global Coronary Artery Bypass Grafts (CABG) Revenue Market Share Forecast by Application (2020-2031)
 Figure 18. Saphenous Vein Grafts of Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Application, 2024 VS 2031
 Figure 19. Internal Thoracic Artery Grafts of Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Application, 2024 VS 2031
 Figure 20. Other of Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Application, 2024 VS 2031
 Figure 21. Coronary Artery Bypass Grafts (CABG) Revenue Share by Company (2024)
 Figure 22. Coronary Artery Bypass Grafts (CABG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Saphenous Vein Grafts Revenue Proportion by Company in 2024
 Figure 24. Internal Thoracic Artery Grafts Revenue Proportion by Company in 2024
 Figure 25. Other Revenue Proportion by Company in 2024
 Figure 26. North America Coronary Artery Bypass Grafts (CABG) Revenue 2020-2031 (US$ Million)
 Figure 27. North America Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Type (2020-2025)
 Figure 28. North America Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Application (2020-2025)
 Figure 29. Asia-Pacific Coronary Artery Bypass Grafts (CABG) Revenue 2020-2031 (US$ Million)
 Figure 30. Asia-Pacific Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Region (2020-2031)
 Figure 31. Asia-Pacific Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Type (2020-2025)
 Figure 32. Asia-Pacific Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Application (2020-2025)
 Figure 33. Europe Coronary Artery Bypass Grafts (CABG) Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 34. Europe Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Country (2020-2031)
 Figure 35. Europe Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Type (2020-2025)
 Figure 36. Europe Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Application (2020-2025)
 Figure 37. Latin America Coronary Artery Bypass Grafts (CABG) Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 38. Latin America Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Country (2020-2031)
 Figure 39. Latin America Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Type (2020-2025)
 Figure 40. Latin America Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Application (2020-2025)
 Figure 41. Middle East and Africa Coronary Artery Bypass Grafts (CABG) Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 42. Middle East and Africa Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Country (2020-2031)
 Figure 43. Middle East and Africa Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Type (2020-2025)
 Figure 44. Middle East and Africa Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Application (2020-2025)
 Figure 45. Coronary Artery Bypass Grafts (CABG) Supply Chain (Upstream and Downstream Market)
 Figure 46. Global Production Market Share of Coronary Artery Bypass Grafts (CABG) Raw Materials by Region in 2024
 Figure 47. Coronary Artery Bypass Grafts (CABG) Distribution Channels
 Figure 48. Global Coronary Artery Bypass Grafts (CABG) Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 49. Global Coronary Artery Bypass Grafts (CABG) Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 50. Bottom-up and Top-down Approaches for This Report
 Figure 51. Data Triangulation
 Figure 52. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS